Rasio utang jangka cendhak marang ekuitas: Minerva Neurosciences (NERV)
The price history on the Minerva Neurosciences (NERV) chart on the GURU.Markets platform demonstrates the dynamics of an asset valued at 0.00. The brand maintains high authority among physicians due to its success in treating severe psychoses. However, the business faces intense pressure from industry behemoths and high regulatory risks. Management is currently implementing a strategic pivot, correcting research errors to secure FDA drug approval.
Rincian metrik lan analitis perusahaan minervaneurosciences.com (NERV)
- kuotasi lan prakiraan analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data liabilitas lan likuiditas perusahaan:
Utang marang Ekuitas Minerva Neurosciences|NERV - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Minerva Neurosciences, Inc.|NERV - Gunggung kewajiban utang perusahaan|Rasio utang marang kapitalisasi buku Minerva Neurosciences Inc|NERV - Tanggungan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Minerva Neurosciences|Likuiditas cepet minervaneurosciences.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
Analisis dhasar perusahaan:NERV Minerva Neurosciences Corp
Minerva Neurosciences (NERV) is scaling its search for neuropsychiatric drugs through automated bioinformatic protein analysis, which requires significant operating expenses. By analyzing changes in the ratio of short-term debt to equity, an investor assesses the volume of liabilities due within one year relative to equity, using this indicator to identify the risk of cash flow gaps or costs associated with upgrading laboratory equipment.
Karo sapa Minerva Neurosciences saingan
Utang jangka cendhak marang modal BIIB|NBIX - Kewajiban jangka cendhak marang modal|Regencell Bioscience - Rasio utang jangka cendhak marang ekuitas|Utang jangka cendhak marang modal axsome.com AXSM|ACAD - Utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal XENE (Xenon Pharmaceuticals Inc.)|Viking Pharma (VKTX) - Utang jangka cendhak marang ekuitas|Kewajiban jangka cendhak marang modal Supernus Corp (SUPN)|Utang jangka cendhak marang ekuitas Catalyst Pharmaceuticals|Rasio utang jangka cendhak marang ekuitas denalitherapeutics.com (DNLI)|Utang jangka cendhak marang modal HRMY|Koefisien utang jangka cendhak marang modal Biohaven Ltd|Utang jangka cendhak marang ekuitas Amylyx AMLX|TRVI: Rasio utang jangka cendhak marang modal|Praxis Precision Medicines - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal anavex.com|CeriBell (CBLL) - Utang jangka cendhak marang ekuitas|Prothena Biosciences - Rasio tanggungan utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas ALEC|Utang jangka cendhak marang ekuitas ANNX|Utang jangka cendhak marang modal OMER|Utang jangka cendhak marang modal neurogene.com (NGNE)|AC Immune SA - Rasio utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal VYGR|NMRA - Utang jangka cendhak marang ekuitas|SCLX (Scilex Holding Company, Inc.) - Rasio utang jangka cendhak marang modal|TVGN: Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Alpha Cognition Inc. (ACOG)|Rasio utang jangka cendhak marang ekuitas CGTX|Utang jangka cendhak marang modal Inhibikase Therapeutics Inc|Utang jangka cendhak marang ekuitas Cassava (SAVA)|ASRT (assertiotx.com) - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Coya Therapeutics COYA|VistaGen Therapeutics, Inc. (VTGN) - Kewajiban jangka cendhak marang modal|OVID - Utang jangka cendhak marang ekuitas|Koefisien utang jangka cendhak marang modal Acumen Pharmaceuticals Inc. ABOS|CRVO: Utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas Alterity Therapeutics Limited|CLNN (Clene Inc) - Utang jangka cendhak marang modal|PepGen Corp (PEPG) - Koefisien utang jangka cendhak marang modal|Utang jangka cendhak marang modal JUNS|RLMD - Kewajiban jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Annovis Bio Corp ANVS|GRCE: Rasio utang jangka cendhak marang modal|Firefly Neuroscience, Inc - Utang jangka cendhak marang modal|Klotho Neurosciences Inc (KLTO) - Rasio utang jangka cendhak marang ekuitas|NRSN: Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Reviva Pharmaceuticals Holdings Inc. (RVPH)|Utang jangka cendhak marang ekuitas MetaVia Inc.|NeurAxis Inc (NRXS) - Koefisien utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Helius Medical (HSDT)|passagebio.com - Rasio utang jangka cendhak marang modal|Utang jangka cendhak marang modal NEUP (Neuphoria Therapeutics)|Athira Pharma Inc (ATHA) - Kewajiban jangka cendhak marang modal|ADXN - Utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal ALZN (Alzamend Neuro, Inc.)|CYCN (cyclerion.com) - Rasio utang jangka cendhak marang ekuitas|PTIX (Protagenic Therapeutics, Inc.) - Utang jangka cendhak marang ekuitas|Utang jangka cendhak marang ekuitas Pasithea Therapeutics Corp|Rasio utang jangka cendhak marang modal CRGT (Cortigent Medical)|Utang jangka cendhak marang modal ATXI|BCLI - Kewajiban jangka cendhak marang modal|Cara Therapeutics, Inc. - Rasio utang jangka cendhak marang ekuitas|Utang jangka cendhak marang modal chromocell.com CHRO|ELYM - Utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal ITCI (Intra-Cellular Therapies)|Longboard Pharma (LBPH) - Utang jangka cendhak marang ekuitas|Kewajiban jangka cendhak marang modal Marinus Pharma (MRNS)|Utang jangka cendhak marang ekuitas NKGen Biotech, Inc.|Rasio utang jangka cendhak marang ekuitas neurobopharma.com (NRBO)|Utang jangka cendhak marang modal SAGE|Koefisien utang jangka cendhak marang modal Synaptogenix Inc.|Utang jangka cendhak marang ekuitas Trevena, Inc TRVN|VIGL: Rasio utang jangka cendhak marang modal|Anew Medical, Inc. - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal cerevel.com